Literature DB >> 33826072

Quantitative Analysis of Serum Zinc Levels in Primary Brain Tumor Patients.

Zeynep Haşimoğlu1, Zübeyde Erbayraktar2, Erdener Özer3, Serhat Erbayraktar4, Tuğba Erkmen2.   

Abstract

Although the close relationships between most of the trace elements and tumor formation mechanisms are very well-defined, studies on some elements such as zinc are still ongoing. When examining studies on brain tumors, it was observed that studies investigating the role played by serum zinc levels on tumor etiology and prognosis have gained momentum. In this study, we investigate the relationship between different brain tumor types and serum zinc levels by quantitatively analyzing serum zinc levels in patients with primary brain tumors. In this study, we measured serum zinc levels of 33 brain tumor patients as well as 35 healthy individuals serving as a control group. Metal concentrations were measured using atomic absorption spectrophotometry. Serum zinc levels were lower in patients with primary brain tumors compared to control group (p < 0.05). Additionally, patients' serum zinc levels were significantly different according to their brain tumor types and also according to their age (p < 0.05). Our findings suggest that brain tumor patients' serum zinc levels may play a role in tumor etiology, typology, and prognosis.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Brain tumors; Malignancy grade; Trace elements; Zinc

Mesh:

Substances:

Year:  2021        PMID: 33826072     DOI: 10.1007/s12011-021-02698-y

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  10 in total

Review 1.  The antioxidant properties of zinc.

Authors:  S R Powell
Journal:  J Nutr       Date:  2000-05       Impact factor: 4.798

2.  Zinc-65 imaging of rat brain tumors.

Authors:  A Takeda; H Tamano; S Enomoto; N Oku
Journal:  Cancer Res       Date:  2001-07-01       Impact factor: 12.701

3.  Antiproliferative and apoptotic effects of zinc-citrate compound (CIZAR(R)) on human epithelial ovarian cancer cell line, OVCAR-3.

Authors:  Seog Nyeon Bae; Yong Seok Lee; Mi Yun Kim; Jae Dong Kim; Lae Ok Park
Journal:  Gynecol Oncol       Date:  2006-04-19       Impact factor: 5.482

4.  Cytotoxic effect of zinc-citrate compound on choriocarcinoma cell lines.

Authors:  S N Bae; J Kim; Y S Lee; J D Kim; M Y Kim; L-O Park
Journal:  Placenta       Date:  2006-02-28       Impact factor: 3.481

Review 5.  The biochemical basis of zinc physiology.

Authors:  B L Vallee; K H Falchuk
Journal:  Physiol Rev       Date:  1993-01       Impact factor: 37.312

Review 6.  The physiological role of zinc as an antioxidant.

Authors:  T M Bray; W J Bettger
Journal:  Free Radic Biol Med       Date:  1990       Impact factor: 7.376

7.  Aggressive phenotypic and genotypic features in pediatric and NF2-associated meningiomas: a clinicopathologic study of 53 cases.

Authors:  A Perry; C Giannini; R Raghavan; B W Scheithauer; R Banerjee; L Margraf; D C Bowers; R A Lytle; I F Newsham; D H Gutmann
Journal:  J Neuropathol Exp Neurol       Date:  2001-10       Impact factor: 3.685

8.  Concentration of elements in human brain: glioblastoma multiforme.

Authors:  E Andrási; M Suhajda; I Sáray; L Bezúr; L Ernyei; A Réffy
Journal:  Sci Total Environ       Date:  1993-11-01       Impact factor: 7.963

Review 9.  Epidemiology of primary brain tumors: current concepts and review of the literature.

Authors:  Margaret Wrensch; Yuriko Minn; Terri Chew; Melissa Bondy; Mitchel S Berger
Journal:  Neuro Oncol       Date:  2002-10       Impact factor: 12.300

10.  Serum and tissue zinc in epithelial malignancies: a meta-analysis.

Authors:  Jaromir Gumulec; Michal Masarik; Vojtech Adam; Tomas Eckschlager; Ivo Provaznik; Rene Kizek
Journal:  PLoS One       Date:  2014-06-18       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.